Healthpeak Properties: Potential Life Science Rebound Creates A Strong Re-Rating Setup
Healthpeak Properties is reiterated as a Buy, driven by resilient earnings, another guidance boost, and a compelling valuation offering a good margin of safety. DOC's Lab segment shows signs of stabilization and potential rebound, supported by strong occupancy gains and positive leasing momentum. Outpatient Medical and Senior Housing segments deliver robust growth, with Senior Housing posting a 25.9% NOI increase amid very strong performance from Janus Living.
